1.Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media in Korean.
Hee Hyun KIM ; Ji Yeob CHOI ; Min Kyung OH ; Eun Young KIM ; Jong Ryul GHIM ; Seok Jin CHOI ; Jae Gook SHIN
Journal of Korean Society for Clinical Pharmacology and Therapeutics 2012;20(2):165-174
BACKGROUND: This study was performed to evaluate the prevalence and risk factors on the adverse reactions caused by iodinated contrast media (CM) for computed tomography (CT) examination in a university hospital. METHODS: Clinical and demographic data among outpatients with CM use were collected at 0000 University Busanpaik Hospital in Busan, Korea between 2008 and 2010. Adverse reaction rate was calculated by the number of adverse reaction among total outpatients with CM use, which was stratified by seasons and sex. The association of risk factors on adverse reaction was investigated using logistic regression model. RESULTS: The total outpatients and events of administered CMs were 27,587 and 48,616, respectively. The administered CMs were iopromide, iohexol, iobitridol, and iodixanol. Adverse reactions occurred in 300 outpatients among the total outpatients (1.1 %). The number of outpatients administered CM more than twice were 8,348. Among them, outpatients who experienced adverse reaction(s) more than once and twice were 124 (1.5 %) and 26 (0.3 %), respectively. Adverse reaction rate was significantly different by sex(p=0.01). The other risk factors were cancer history (OR 2.57, 95 % CI 2.00-3.31) and previous CM administration (OR 1.89, 95 % CI 1.47-2.44). Urticaria was the most frequent symptoms. CONCLUSION: Total adverse reaction rate was 1.1 % with most common symptom in skin system. Related risk factors were female, cancer history, and previous CM administration. These results were similar to previous studies and will be contribute to clinical practice and future research especially in Koreans.
Contrast Media
;
Female
;
Humans
;
Iohexol
;
Korea
;
Logistic Models
;
Outpatients
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Seasons
;
Skin
;
Triiodobenzoic Acids
;
Urticaria
2.Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media in Korean.
Hee Hyun KIM ; Ji Yeob CHOI ; Min Kyung OH ; Eun Young KIM ; Jong Ryul GHIM ; Seok Jin CHOI ; Jae Gook SHIN
Journal of Korean Society for Clinical Pharmacology and Therapeutics 2012;20(2):165-174
BACKGROUND: This study was performed to evaluate the prevalence and risk factors on the adverse reactions caused by iodinated contrast media (CM) for computed tomography (CT) examination in a university hospital. METHODS: Clinical and demographic data among outpatients with CM use were collected at 0000 University Busanpaik Hospital in Busan, Korea between 2008 and 2010. Adverse reaction rate was calculated by the number of adverse reaction among total outpatients with CM use, which was stratified by seasons and sex. The association of risk factors on adverse reaction was investigated using logistic regression model. RESULTS: The total outpatients and events of administered CMs were 27,587 and 48,616, respectively. The administered CMs were iopromide, iohexol, iobitridol, and iodixanol. Adverse reactions occurred in 300 outpatients among the total outpatients (1.1 %). The number of outpatients administered CM more than twice were 8,348. Among them, outpatients who experienced adverse reaction(s) more than once and twice were 124 (1.5 %) and 26 (0.3 %), respectively. Adverse reaction rate was significantly different by sex(p=0.01). The other risk factors were cancer history (OR 2.57, 95 % CI 2.00-3.31) and previous CM administration (OR 1.89, 95 % CI 1.47-2.44). Urticaria was the most frequent symptoms. CONCLUSION: Total adverse reaction rate was 1.1 % with most common symptom in skin system. Related risk factors were female, cancer history, and previous CM administration. These results were similar to previous studies and will be contribute to clinical practice and future research especially in Koreans.
Contrast Media
;
Female
;
Humans
;
Iohexol
;
Korea
;
Logistic Models
;
Outpatients
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Seasons
;
Skin
;
Triiodobenzoic Acids
;
Urticaria
3.Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB.
Seung Heon LEE ; Kyung Ah SEO ; Young Min LEE ; Hyun Kyung LEE ; Je Hyeong KIM ; Chol SHIN ; Jong Ryul GHIM ; Jae Gook SHIN ; Dong Hyun KIM
Yonsei Medical Journal 2015;56(4):961-967
PURPOSE: Low serum concentrations of drugs used to treat multi-drug resistant tuberculosis (MDR-TB) have occasionally been associated with treatment failure. We determined the frequencies of low serum concentrations of anti-MDR-TB drugs, and assessed the effects of these concentrations on 2-month sputum conversion. MATERIALS AND METHODS: The serum levels of moxifloxacin (MF), prothionamide (PTH), and cycloserine (CS) were determined for 89 serum samples by high-pressure liquid chromatography-tandem mass spectrometry. RESULTS: Low serum concentrations of MF, PTH, and CS below the minimal levels of the normal ranges were 83.3% (20/24), 59.2% (29/49), and 71.2% (47/66), respectively. There were no significant differences between the 2-month sputum conversion group (n=25) and the 2-month sputum non-conversion group (n=4) in median drug concentrations (microg/mL) of MF (1.46 vs. 1.60), PTH (0.91 vs. 0.70), and CS (14.90 vs. 14.90). However, a poor compliance rate was significantly greater in the 2-month sputum non-conversion group (75.0%, 3/4) than in the 2-month sputum conversion group (0%, 0/25) (p=0.001). CONCLUSION: The frequency of low serum concentrations of anti-MDR-TB drugs was substantial and might not affect the 2-month sputum conversion rate. Larger prospective studies with timely sampling are needed to investigate the role of therapeutic drug monitoring in MDR-TB.
Adult
;
Aged
;
Antitubercular Agents/blood/*pharmacokinetics/therapeutic use
;
Chromatography, High Pressure Liquid
;
Cycloserine/blood/*pharmacokinetics/therapeutic use
;
Fluoroquinolones/blood/*pharmacokinetics/therapeutic use
;
Humans
;
Medication Adherence
;
Middle Aged
;
Prothionamide/blood/*pharmacokinetics/therapeutic use
;
Retrospective Studies
;
Sputum/*microbiology
;
Tandem Mass Spectrometry
;
Tuberculosis, Multidrug-Resistant/blood/*drug therapy
;
Young Adult
4.Effects of Increased Lymphocytes and B Cell Clonality of Marrow Aspirates on Marrow Involvement and Prognosis in Children with Neuroblastoma.
Yoon Hee KANG ; Chan Jeoung PARK ; Mee Jung KIM ; Eul Ju SEO ; Sung Ryul KIM ; Hyun Sook CHI ; Yong Hee SHIM ; Joo Ryung HUR ; Jong Jin SEO ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Hematology 1999;34(4):521-533
BACKGROUND: The lymphocytes including morphologically immature lymphoid cells are frequently increased in the marrow aspirates of children with neuroblastoma. We studied about the clonality of these lymphoid cells and its effects on the marrow involvement and prognosis of disease. METHODS: We evaluated 30 marrow aspirates of 23 children with neuroblastoma from 1990 to 1998. We tested the immunoglobulin heavy chain gene rearrangement PCR for B cell clonality and T cell receptor gamma gene rearrangement PCR for T cell clonality with bone marrow specimens. RESULTS: Younger children showed negative bone marrow involvement more than older children. In this group, the proportions of immature lymphoid cells and total lymphocytes were higher (3.4+/-3.2% vs. 0.8+/-1.9%, 31.3+/-17.0% vs. 14.7+/-12.0%). Immunoglobulin heavy chain gene rearrangements were present in 19/30 (64%) specimens and more frequently observed in negative marrow involvement cases. Seven cases with the proportions of total lymphocytes more than 30% showed significantly high long-term survival probability (P=0.05). Ten cases with B cell monoclonality showed the tendency of high long-term survival probability (P=0.13). CONCLUSION: The increase of lymphocytes including morphologically immature lymphoid cells in the marrow aspirates of children with neuroblastoma were frequently observed in the children without marrow involvement of malignancy and closely related to B cell clonality. The increase of total lymphocytes and related B cell monoclonality may be one of possible explanations of goodprognosis of children with neuroblastoma.
Bone Marrow*
;
Child*
;
Gene Rearrangement
;
Humans
;
Immunoglobulin Heavy Chains
;
Lymphocytes*
;
Neuroblastoma*
;
Polymerase Chain Reaction
;
Prognosis*
;
Receptors, Antigen, T-Cell